Gregory Kapp, San Francisco, CA (US); Laura Serwer, Brisbane, CA (US); Natacha Le Moan, San Francisco, CA (US); and Stephen P. L. Cary, San Mateo, CA (US)
Assigned to OMNIOX, INC., San Carlos, CA (US)
Filed by Omniox, Inc., San Carlos, CA (US)
Filed on Aug. 9, 2021, as Appl. No. 17/397,577.
Application 16/931,736 is a division of application No. 16/450,913, filed on Jun. 24, 2019, granted, now 10,766,947, issued on Sep. 8, 2020.
Application 17/397,577 is a continuation of application No. 16/931,736, filed on Jul. 17, 2020, granted, now 11,117,952.
Application 16/450,913 is a continuation of application No. 14/759,635, granted, now 10,385,116, issued on Aug. 20, 2019, previously published as PCT/US2013/020602, filed on Jan. 7, 2013.
Prior Publication US 2022/0048977 A1, Feb. 17, 2022
1. A method of delivering oxygen to a brain tumor in an individual with a brain cancer comprising administering an effective amount of a trimeric H-NOX protein comprising three H-NOX monomers, to the individual.